VNDA — VANDA PHARMACEUTICALS INC COM

Ownership history in ALGERT GLOBAL LLC  ·  10 quarters on record

This page tracks every 13F SEC filing in which ALGERT GLOBAL LLC reported a position in VANDA PHARMACEUTICALS INC COM (VNDA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.56% (2018 Q4)
Avg. % of fund
0.15%
First filed
2012 Q4
Last filed
2025 Q3
Quarters held
10
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 34,934 +8,024 +29.8% 0.00% $174K $4.99
2025 Q1 ADDED 26,910 +15,080 +127.5% 0.00% $124K $4.59
2022 Q3 REDUCED 11,830 -64,374 -84.5% 0.01% $117K $9.88
2018 Q4 ADDED 76,204 +57,981 +318.2% 0.56% $2.0M $26.13
6 older quarters hidden  —  Sign in free or upgrade to Premium to see full history
% of Fund (quarterly)    VNDA price (monthly, adj. close)

Other funds also holding VNDA

As of 2025 Q4 — sorted by position size

AIGH Capital Management LLC 3Y 4.27% Krensavage Asset Management, LLC 3Y 7Y 3.68% Empire Financial Management Company, LLC 2.12% Monaco Asset Management SAM 3Y 0.3% Sassicaia Capital Advisers LLC 3Y 0.28% KOTLER KEVIN 0.21% GSA CAPITAL PARTNERS LLP 3Y 7Y 0.11% STEMPOINT CAPITAL LP 0.09% Inscription Capital, LLC 3Y 0.06% AXQ CAPITAL, LP 3Y 0.05%
← Back to ALGERT GLOBAL LLC Holdings